Verona Pharma’s Post

Verona Pharma reposted this

View organization page for Verona Pharma, graphic

14,876 followers

BREAKING NEWS: Today, the US FDA approved our drug for the maintenance treatment of #COPD in adults, making it the first inhaled product with a novel mechanism of action for this indication in over 20 years.    Learn more: https://bit.ly/4bnUSxt     #FDAApproval 

Eddie French

Director, TEKH Consulting Limited

1mo

Fantastic news . A long and sometimes torturous journey successfully navigated. Many congratulations to all the team and those who have been involved over many years of its development.

Nayna Govind

Executive Director Project Leader at Pulmocide Ltd

1mo

Congratulations to Verona and everyone involved in reaching this fantastic milestone!

Kathy Abbott-Banner

Clinical Sciences Respiratory at GSK

1mo

Many Congratulations to the current team at Verona Pharma and indeed all my former collegaues who worked on this asset in the past. Proud to have been a part of its development!

Philippe, You are not forgotten. Congrats on this great achievement. You are always in our thoughts and prayers. Michael Tutcher is no longer the person we knew. He has dementia. We will visit you when we come to London. Give us your e-mail to keep in touch with much love. Shirley and Marlyn.

Like
Reply
Claudia Baerlin-Gallegos

Multilingual highly strategic Business Development Manager Pharmaceutical, Biotech and Device specialist with Molecular Biology background

1mo

Congratulations 🎈 to you and all the patients who will greatly benefit from this amazing molecular 🎈🎈🎈🎈🎈🎈🎈🎈🫁🫁🫁🫁🫁🫁🫁🫁🫁🎈🎈

Like
Reply
Jenn Woodbury, MPH

Achiever | Responsibility | Communication | Developer | Ideation

1mo

Congratulations to the entire company!!! Brilliant news!

A sharp sword against copd. I am a buyer of the shares

Like
Reply
Karthik Chandrasekar, PharmD

Providing Solutions to Biopharma's Most Complex Problems | Consulting Senior Engagement Manager

1mo

Congrats Kavita Aggarwal, Amy Dixon, PharmD, Stephen Fu, and the whole Verona team!

Shakun Karki, PhD

Compassionate, creative, critical thinker Clinical Scientist•17year career focused on cardio metabolic diseases, transitioning to data & clinical science in biomedicine• Awarded NIH grant• Published 20+ manuscripts.

1mo

Nice! Closing the gap in unmet needs is crucial for patients living with COPD, particularly with medications that serve dual purposes: acting as both a bronchodilator and a non-steroidal anti-inflammatory.

Anna Sipitanou

Commercial Director, RHC @ Recipharm | MSc, BSc

1mo

What a success! Well done all people who worked on this over the years and made it possible!

See more comments

To view or add a comment, sign in

Explore topics